Variables | Non-hepatic inflow occlusion | Hepatic inflow occlusion | p-value |
---|---|---|---|
n = 80 | n = 80 | ||
Gender (%) | Â | Â | 0.175 |
 Male | 65 (81.3) | 72 (90.0) |  |
 Female | 15 (18.7) | 8 (10.0) |  |
Age (y) | 45.6 ± 11.4 | 44.4 ± 11.3 | 0.568 |
Length (%) | Â | Â | 0.858 |
  ≤ 5 cm | 21 (26.3) | 22 (27.5) |  |
  > 5 cm | 59 (73.8) | 58 (72.5) |  |
Tumor number (%) | Â | Â | 0.855 |
 Single | 61 (76.3) | 59 (73.8) |  |
 Multiple | 19 (23.8) | 21 (26.3) |  |
BCLC stage (%) | Â | Â | 1.000 |
 A | 48 (60.0) | 48 (60.0) |  |
 B | 20 (25.0) | 20 (25.0) |  |
 C | 12 (15.0) | 12 (15.0) |  |
Child–Pugh (%) |  |  | 0.454 |
 A | 64 (80.0) | 59 (73.8) |  |
 B | 16 (20.0) | 21 (26.3) |  |
AFP (%) | Â | Â | 0.748 |
  ≤ 400 ng/ml | 31 (38.8) | 34 (42.5) |  |
  > 400 ng/ml | 49 (61.3) | 46 (57.5) |  |
Edmondson-steiner (%) | Â | Â | 0.091 |
 I | 11 (13.8) | 7 (8.8) |  |
 II | 28 (35.0) | 43 (53.8) |  |
 III | 26 (32.5) | 16 (20.0) |  |
 IV | 15 (18.8) | 14 (17.5) |  |
Necrosis (%) | Â | Â | 0.205 |
 No | 56 (70.0) | 63 (78.8) |  |
 Yes | 24 (30.0) | 17 (21.3) |  |
Local invasion (%) | Â | Â | 0.635 |
 No | 36 (45.0) | 40 (50.0) |  |
 Yes | 44 (55.0) | 40 (50.0) |  |
ALB (g/L) | 35.3 (32.3–38.1) | 35.6 (32.9–37.8) | 0.889 |
ALT (U/L) | 27.0 (21.0–43.3) | 30.5 (24.0–44.0) | 0.321 |
AST (U/L) | 37.5 (28.5–63.5) | 35.0 (22.3–65.8) | 0.512 |
ALP (U/L) | 76.0 (54.5–94.5) | 76.5 (61.0–91.0) | 0.475 |
GGT (U/L) | 49.5 (28.0–93.3) | 51.5 (35.0–126.8) | 0.280 |
HBsAg (%) | Â | Â | 0.159 |
 No | 14 (17.5) | 7 (8.8) |  |
 Yes | 66 (82.5) | 73 (91.3) |  |